Publications by authors named "Nicholas Keks"

Claim this Profile
W
What clinicians need to know about intranasal esketamine for treatment-resistant depression?
Judy Hope, David Copolov, John Tiller, Megan Galbally, Malcolm Hopwood, Nicholas A Keks

Australas Psychiatry· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between long-term use of prolactin-elevating antipsychotics in women and the risk of breast cancer: What are the clinical implications?
Judith D Hope, Nicholas A Keks, David L Copolov

Australas Psychiatry· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lemborexant, an orexin receptor antagonist sedative-hypnotic: Is it useful for insomnia in psychiatric disorders?
Nicholas A Keks, Judy Hope

Australas Psychiatry· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cariprazine: A new partial dopamine agonist with a familiar profile.
Judy Hope, Nicholas A Keks

Australas Psychiatry· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of inpatients who were readmitted within 28 days of discharge with those not readmitted: an audit at an Australian private psychiatric hospital.
Judith Hope, Nicholas A Keks, William Pring, Voula Adamopoulos, David Toffler

Australas Psychiatry· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics, diagnoses and risk profiles of inpatients readmitted within 28 days of discharge to an Australian private psychiatric hospital.
Nicholas A Keks, Judith Hope, Voula Adamopoulos, William Pring, David Tofler

Australas Psychiatry· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Tolerability of Dopamine D2/3 Receptor Partial Agonists for Schizophrenia.
Nicholas Keks, Judith Hope, Darren Schwartz, Harold McLennan, David Copolov

CNS Drugs· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stopping and switching antipsychotic drugs.
Nicholas Keks, Darren Schwartz, Judy Hope

Aust Prescr· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antipsychotic switching tool.
Nicholas Keks, Darren Schwartz, Judy Hope

Aust Prescr· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics, diagnoses, illness course and risk profiles of inpatients admitted for at least 21 days to an Australian private psychiatric hospital.
Nicholas A Keks, Judy Hope, William Pring, Saji Damodaran, Shashjit Varma

Australas Psychiatry· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Milnacipran: serotonin-noradrenaline reuptake inhibitor approved for fibromyalgia may be a useful antidepressant.
Nicholas A Keks, Judy Hope, Simone Keogh, David L Copolov

Australas Psychiatry· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paliperidone palmitate three-month depot formulation: a helpful innovation with practical pitfalls.
Judith D Hope, Nicholas A Keks

Australas Psychiatry· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brexpiprazole: a new leaf on the partial dopamine agonist branch.
Judy Hope, David Castle, Nicholas A Keks

Australas Psychiatry· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suvorexant: scientifically interesting, utility uncertain.
Nicholas A Keks, Judy Hope, Simone Keogh

Australas Psychiatry· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recovery is a core goal of psychiatrists.
Peter Bosanac, Malcolm Hopwood, Nicholas Keks, Richard Newton, John Wg Tiller

Aust N Z J Psychiatry· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Should ketamine be used for the clinical treatment of depression?
Shalini Arunogiri, Nicholas A Keks, Judy Hope

Australas Psychiatry· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aripiprazole long-acting injection: promising but more evidence needed.
Nicholas A Keks, Judy Hope, Christine Culhane

Australas Psychiatry· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lurasidone: an antipsychotic with antidepressant effects in bipolar depression?
Nicholas A Keks, Judy Hope, David Castle

Australas Psychiatry· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching and stopping antidepressants.
Nicholas Keks, Judy Hope, Simone Keogh

Aust Prescr· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vortioxetine: A multimodal antidepressant or another selective serotonin reuptake inhibitor?
Nicholas A Keks, Judy Hope, Christine Culhane

Australas Psychiatry· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of antidepressant-induced sexual dysfunction.
Nicholas A Keks, Judy Hope, Christine Culhane

Australas Psychiatry· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
'
'Help us, she's fading away': How to manage the patient with anorexia nervosa.
Suzy Redston, John Tiller, Isaac Schweitzer, Nicholas Keks, Graham Burrows

Aust Fam Physician· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological approaches to the management of schizophrenia: 10 years on.
David Castle, Nicholas Keks, Richard Newton, Isaac Schweitzer, David Copolov

Australas Psychiatry· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-acting injectable risperidone v. olanzapine tablets for schizophrenia or schizoaffective disorder. Randomised, controlled, open-label study.
Nicholas A Keks, Michael Ingham, Akbar Khan, Keith Karcher

Br J Psychiatry· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis